Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Unlisted holdings
Data as at : 01/12/2023
| % of total assets |
|---|
| 4.8 |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 31/12/2023
| Investment | % of total assets |
|---|---|
| Amgen Inc | 8.8 |
| Biogen Inc | 8.5 |
| Scholar Rock Holding Corp | 4.8 |
| Biomarin Pharmaceutical Inc | 4.7 |
| Ionis Pharmaceuticals Inc | 4.4 |
| Vaxcyte Inc Ordinary Shares | 4.2 |
| Quantumpharm Inc (Xtalpi) - Pfd | 3.7 |
| Sarepta Therapeutics Inc | 3.7 |
| Neurocrine Biosciences Inc | 3.3 |
| Other Assets And Liabilities | -8.6 |
Geographic breakdown
Data as at : 31/03/2024
| Country | % of total assets |
|---|---|
| USA | 84.5 |
| Netherlands | 4.7 |
| China | 2.9 |
| Canada | 1.3 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 31/03/2024
| Industry | % of total assets |
|---|---|
| Healthcare | 105.0 |
| Preferred | 3.2 |
| Cash Equivalents | 0.6 |
Scroll
Asset breakdown
Data as at : 31/03/2024
| Asset | % of total assets |
|---|---|
| Stock | 108.9 |
| Other | -9.5 |
| Cash/Cash equivalents | 0.6 |
Detailed asset breakdown
Data as at : 31/03/2024
| Asset | % of total assets |
|---|---|
| North America - stock | 100.1 |
| Asia (excl Japan) - stock | 3.4 |
| Preferred stock | 3.2 |
| Europe - Small-cap stock | 1.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
